Cancer regression induced by modified CTL therapy is regulated by HLA class II and class I antigens in Japanese patients with advanced cancer.
Year: 2000
Type: article
Authors: K Araki, Y Noguchi, T Hirouchi, E Yoshikawa, S Kataoka, L Silverni, H Miyazawa, H Kuzuhara, C Suzuki, Y Shimada, S Hamasato, N Maeda, Y Shimamura, Y Ogawa, Y Ohtsuki, S Fujimoto
Institution: Atago Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1983980607